OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

Recombinant antibody production leverages Chinese hamster ovary (CHO) cells due to their robustness in expressing complex biologics. Optimizing these processes involves modifying various variables, including cell line selection, media formulation, and bioreactor environments. A key goal is to amplify antibody titer while minimizing production finan